The world of digital health tools and medical devices, which has seen tremendous growth over the past few years, is about to undergo a significant regulatory shakeup. The Food and Drug Administration (FDA) has begun its pledge to supervise software-driven medical tools manufactured by Johnson & Johnson’s subsidiary, Abiomed.
Last year, in a landmark deal, Johnson & Johnson acquired Abiomed for a whopping $16.6 billion. Abiomed’s portfolio includes sophisticated devices tailored for heart failure patients, complemented by their cutting-edge patient monitoring software. However, the FDA sent a cautionary letter to Abiomed last Wednesday. The core of this warning: Abiomed had allegedly bypassed requisite protocol by not seeking prior FDA approval before launching its software. But there were other allegations. The FDA further expressed its concerns regarding Abiomed’s purported neglect in addressing issues related to its heart pumps.
This unprecedented move by the FDA was expected. Roughly a year ago, the agency had already declared its intent to heighten its scrutiny over health software tools, prompting concern throughout the medical-tech industry. A crucial aspect of these devices consists of clinical decision-support tools. Enhanced by the power of artificial intelligence, these tools serve as indispensable aids to healthcare professionals, guiding them in deciphering treatment paths or anticipating patient risks. Until now, the FDA has adopted a hands-off approach concerning these tools. But the perils of such an approach were starkly highlighted by STAT’s probe into a faulty sepsis algorithm created by Epic. The malfunction of such tools directly jeopardizes patient safety, underscoring the urgency of regulatory intervention.
As the FDA delves deeper into ensuring the safety and efficacy of health software tools, the potential for product liability lawsuits becomes more pronounced. For victims of malfunctions or lapses in these tools, understanding the legal pathway is crucial.
Initiating a lawsuit involves filing a claim that alleges that the product (in this case, a health software tool) was defective and that this defect led to injury or harm. The process begins with thorough evidence collection. Here, the victim would need to collate medical records, expert testimonies, and other pertinent documentation that underscores the direct link between the product’s malfunction and the consequent harm.
Having an attorney is paramount at each step of this process, from understanding the nuances of the case to presenting a compelling case in court. Furthermore, attorneys are adept at negotiations, ensuring that victims receive the rightful compensation their cases deserve.
The damages in a product liability lawsuit could range from compensatory to punitive. Compensatory damages cover the tangible and intangible costs the victim has incurred, such as medical bills or emotional distress. Punitive damages, on the other hand, are levied to penalize the erring company and deter it and others from similar negligence in the future.
CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW
For those who have experienced harm due to faulty medical software tools, now is the moment to seek justice. The national product injury law firm, Parker Waichman LLP, stands ready to assist. With a track record of fighting for victims’ rights, their team is well-equipped to handle the complexities of product liability cases. Don’t let big corporations deter you from pursuing your rightful claim. Contact us today for your free consultation. Your path to justice is just a call away at 1-800-YOUR-LAWYER (1-800-968-7529). Your well-being and peace of mind deserve nothing less than the best legal representation.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation